Nasal Spray May Be Weight-Loss Aid

NOVEMBER 01, 2004
Susan Farley

Merck & Co Inc, in partnership with Nastech Pharmaceutical Co Inc, began small-scale testing of a nasal spray drug that would make people feel full. Nastech's president and chief executive officer, Steven C. Quay, MD, PhD, said that, if further testing of the drug goes well, then patients' daily caloric intake could be reduced by 30%, which could mean a weight loss of ~50 lb over the course of 1 year on a 2800-calorie/day diet. The active compound Peptide YY (PYY) 3-36 Nasal Spray is based on a hormone made by the intestines that tells the brain that the body is full ~30 to 45 minutes after a person eats. The spray would be used before eating and, depending on the results of testing, would be taken either once daily or before each meal. Preliminary testing on 60 people yielded favorable results. Both companies hope that PYY 3-36 will help control the obesity epidemic as well as its related health problems, including diabetes, high blood pressure, heart disease, arthritis, and cancer.



SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.